129 related articles for article (PubMed ID: 15050986)
1. Clinical and metabolic findings in adolescent females with hyperandrogenism.
Huppert J; Chiodi M; Hillard PJ
J Pediatr Adolesc Gynecol; 2004 Apr; 17(2):103-8. PubMed ID: 15050986
[TBL] [Abstract][Full Text] [Related]
2. [Correlations between clinical signs and hormonal parameters in young women with hirsutism].
Kristesashvili J; Chanukvadze D
Georgian Med News; 2011 Nov; 11(200):30-5. PubMed ID: 22201077
[TBL] [Abstract][Full Text] [Related]
3. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
[TBL] [Abstract][Full Text] [Related]
4. Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.
Pinola P; Lashen H; Bloigu A; Puukka K; Ulmanen M; Ruokonen A; Martikainen H; Pouta A; Franks S; Hartikainen AL; Järvelin MR; Morin-Papunen L
Hum Reprod; 2012 Nov; 27(11):3279-86. PubMed ID: 22933528
[TBL] [Abstract][Full Text] [Related]
5. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
Karrer-Voegeli S; Rey F; Reymond MJ; Meuwly JY; Gaillard RC; Gomez F
Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
[TBL] [Abstract][Full Text] [Related]
6. Acne severity and the Global Acne Grading System in polycystic ovary syndrome.
Hacivelioglu S; Gungor AN; Gencer M; Uysal A; Hizli D; Koc E; Cosar E
Int J Gynaecol Obstet; 2013 Oct; 123(1):33-6. PubMed ID: 23948280
[TBL] [Abstract][Full Text] [Related]
7. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
8. Androgen excess: Investigations and management.
Lizneva D; Gavrilova-Jordan L; Walker W; Azziz R
Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():98-118. PubMed ID: 27387253
[TBL] [Abstract][Full Text] [Related]
9. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
10. [The evaluation of clinical signs and hormonal changes in women who complained of excessive body hair growth].
Kozloviene D; Kazanavicius G; Kruminis V
Medicina (Kaunas); 2005; 41(6):487-95. PubMed ID: 15998987
[TBL] [Abstract][Full Text] [Related]
11. Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne.
Timpatanapong P; Rojanasakul A
J Dermatol; 1997 Apr; 24(4):223-9. PubMed ID: 9164062
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Findings and Systemic Associations in Women With Polycystic Ovary Syndrome.
Schmidt TH; Khanijow K; Cedars MI; Huddleston H; Pasch L; Wang ET; Lee J; Zane LT; Shinkai K
JAMA Dermatol; 2016 Apr; 152(4):391-8. PubMed ID: 26720591
[TBL] [Abstract][Full Text] [Related]
13. Management of hyperandrogenism in adolescent girls.
Sultan C; Medlej R; Chevalier C; Lobaccaro JM
Horm Res; 1991; 36(3-4):160-4. PubMed ID: 1840143
[TBL] [Abstract][Full Text] [Related]
14. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.
Li L; Chen X; He Z; Zhao X; Huang L; Yang D
J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):390-5. PubMed ID: 23089573
[TBL] [Abstract][Full Text] [Related]
15. Lower insulin sensitivity differentiates hirsute from non-hirsute Sicilian women with polycystic ovary syndrome.
Amato MC; Galluzzo A; Merlino S; Mattina A; Richiusa P; Criscimanna A; Giordano C
Eur J Endocrinol; 2006 Dec; 155(6):859-65. PubMed ID: 17132756
[TBL] [Abstract][Full Text] [Related]
16. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
17. Does obesity diminish the positive effect of oral contraceptive treatment on hyperandrogenism in women with polycystic ovarian syndrome?
Cibula D; Hill M; Fanta M; Sindelka G; Zivny J
Hum Reprod; 2001 May; 16(5):940-4. PubMed ID: 11331641
[TBL] [Abstract][Full Text] [Related]
18. An updated clinico-investigative approach to diagnosis of cutaneous hyperandrogenism in relation to adult female acne, female pattern alopecia & hirsutism a primer for dermatologists.
Sardana K; Muddebihal A; Sehrawat M; Bansal P; Khurana A
Expert Rev Endocrinol Metab; 2024 Mar; 19(2):111-128. PubMed ID: 38205927
[TBL] [Abstract][Full Text] [Related]
19. Acne, hirsutism, and alopecia in adolescent girls. Clinical expressions of androgen excess.
Rosenfield RL; Lucky AW
Endocrinol Metab Clin North Am; 1993 Sep; 22(3):507-32. PubMed ID: 8243445
[TBL] [Abstract][Full Text] [Related]
20. Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism.
Carmina E; Rosato F; Jannì A; Rizzo M; Longo RA
J Clin Endocrinol Metab; 2006 Jan; 91(1):2-6. PubMed ID: 16263820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
